A. Forastiere

Otorhinolaryngology · 2001–2021

A researcher in the Science corpus: 16 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Otorhinolaryngology — 56 citations into it; #14 of 16 by trust here, #2 by citations

Whom A. Forastiere trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Gillison

Who trusts A. Forastiere overall

1. S. Marur

Papers from A. Forastiere's perspective

Ordered by how strongly the researchers A. Forastiere trusts endorse each paper. Same corpus, a different order for every researcher.

1. Nonparametric Estimation from Incomplete Observations
2. Case-control study of human papillomavirus and oropharyngeal cancer. (New England Journal of Medicine)
3. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
4. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer (New England Journal of Medicine)
5. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. (New England Journal of Medicine)
6. Prevalence of Oral HPV Infection in the United States, 2009–2010 (Journal of the American Medical Association (JAMA))
7. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. (Radiotherapy and Oncology)
8. HPV-associated Head and Neck Cancer: A Virus-related Cancer Epidemic – A Review of Epidemiology, Biology, Virus Detection and Issues in Management (The Lancet Oncology)
9. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (New England Journal of Medicine)
10. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. (Journal of Clinical Oncology)

Their papers

• TP53 mutations and survival in squamous-cell carcinoma of the head and neck. (2007) — 780 citations
• Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. (2005) — 812 citations
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group (2021)
• Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. (2016) — 1,082 citations
• Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. (2013) — 1,146 citations
• HPV-associated Head and Neck Cancer: A Virus-related Cancer Epidemic – A Review of Epidemiology, Biology, Virus Detection and Issues in Management (2010) — 1,776 citations
• Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. (2008) — 1,332 citations
• Head and neck cancer: changing epidemiology, diagnosis, and treatment. (2008) — 760 citations
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. (2008) — 2,711 citations
• Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. (2008) — 656 citations
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) (2005) — 1,688 citations
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (2004) — 3,023 citations
• An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. (2003) — 1,689 citations
• Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. (2003) — 2,970 citations
• Head and neck cancer. (2001) — 675 citations
• Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. (2001) — 1,308 citations